PhRMA Sues To Block 'Unprecedented' California Price Reporting Law

Ban on WAC price increases violates Commerce Clause and reporting requirement violates First Amendment, PhRMA contends; complaint says state officials have not clarified whether law is retroactive.

court house

Six years after winning a landmark case challenging a Vermont statute's restriction of pharma marketing practices, the Pharmaceutical Research and Manufacturers of America (PhRMA) is seeking to strike down a California law restricting drug company pricing practices.

On Dec. 8, PhRMA filed suit against California Governor Jerry Brown, Jr. and Robert David, director of the California...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access